Literature DB >> 9765424

CD4 promoter transactivation by human herpesvirus 6.

L Flamand1, F Romerio, M S Reitz, R C Gallo.   

Abstract

The observation that human herpesvirus 6 (HHV-6) can induce CD4 gene transcription and expression in CD4(-) cells was reported several years ago (P. Lusso, A. De Maria, M. Malnati, F. Lori, S. E. DeRocco, M. Baseler, and R. C. Gallo, Nature 349:533-535, 1991) and subsequently confirmed (P. Lusso, M. S. Malnati, A. Garzino-Demo, R. W. Crowley, E. O. Long, and R. C. Gallo, Nature 362:458-462, 1993; G. Furlini, M. Vignoli, E. Ramazzotti, M. C. Re, G. Visani, and M. LaPlaca, Blood 87:4737-4745, 1996). Our objective was to identify the mechanisms underlying such phenomena. Using reporter gene constructs driven by the CD4 promoter, we report that HHV-6 can efficiently transactivate such genetic elements. Activation of the CD4 promoter occurs in the presence of the viral DNA polymerase inhibitor phosphonoformic acid, which limits expression to the immediate-early and early classes of viral genes. Using deletion mutants and specific CD4 promoter mutants, we identified an ATF/CRE binding site located at nucleotides -67 to -60 upstream of the CD4 gene transcription start site that is important for HHV-6 transactivation. The ATF/CRE site is also essential for CD4 promoter activation by forskolin, an activator of adenylate cyclase. Using electrophoretic mobility shift assays and specific antibodies, we showed that CREB-1 binds specifically to the -79 to -52 region of the CD4 promoter. Last, we have identified two open reading frames (ORFs) of HHV-6, U86 and U89 from the immediate-early locus A, that can transactivate the CD4 promoter in HeLa cells. However, transactivation of the CD4 promoter by ORFs U86 and U89 is independent of the CRE element, suggesting that additional HHV-6 ORFs are likely to contribute to CD4 gene activation. Taken together, our results will help to understand the complex interactions occurring between HHV-6 and the CD4 promoter and provide additional information regarding the class of transcription factors involved in the control of CD4 gene expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765424      PMCID: PMC110296     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Interaction between CD4 and class II MHC molecules mediates cell adhesion.

Authors:  C Doyle; J L Strominger
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

2.  Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

Authors:  R T Horvat; C Wood; N Balachandran
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 3.  Molecular biology and function of CD4 and CD8.

Authors:  J R Parnes
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 4.  Specialized protein tyrosine kinase proto-oncogenes in hematopoietic cells.

Authors:  R M Perlmutter; J D Marth; S F Ziegler; A M Garvin; S Pawar; M P Cooke; K M Abraham
Journal:  Biochim Biophys Acta       Date:  1989-02

5.  Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

Authors:  P Lusso; B Ensoli; P D Markham; D V Ablashi; S Z Salahuddin; E Tschachler; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

6.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

7.  Isolation of a new human herpesvirus producing a lytic infection of helper (CD4) T-lymphocytes in peripheral blood lymphocyte cultures--another cause of acquired immunodeficiency?

Authors:  W B Becker; S Engelbrecht; M L Becker; C Piek; B A Robson; L Wood; P Jacobs
Journal:  S Afr Med J       Date:  1988-12-17

8.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

9.  Nucleotide sequence analysis of a 21-kbp region of the genome of human herpesvirus-6 containing homologues of human cytomegalovirus major immediate-early and replication genes.

Authors:  J Nicholas
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

10.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Authors:  C E Rudd; J M Trevillyan; J D Dasgupta; L L Wong; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  12 in total

1.  Precise arrangement of factor-binding sites is required for murine CD4 promoter function.

Authors:  S Sarafova; G Siu
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

2.  Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument protein.

Authors:  Mathieu Iampietro; Guillaume Morissette; Annie Gravel; Louis Flamand
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV?

Authors:  Darrell H S Tan; Rupert Kaul; Sharon Walsmley
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

5.  Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.

Authors:  Andru Tomoiu; Annie Gravel; Robert M Tanguay; Louis Flamand
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  ATF1 Restricts Human Herpesvirus 6A Replication via Beta Interferon Induction.

Authors:  Salma Aktar; Jun Arii; Thi Thu Huong Nguyen; Jing Rin Huang; Mitsuhiro Nishimura; Yasuko Mori
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

Review 7.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo.

Authors:  Jean-Charles Grivel; Fabio Santoro; Silvia Chen; Giovanni Fagá; Mauro S Malnati; Yoshinori Ito; Leonid Margolis; Paolo Lusso
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 10.  New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology.

Authors:  Philippe Musette; Baptiste Janela
Journal:  Front Med (Lausanne)       Date:  2017-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.